Skip to main content
Log in

Reviewing evidence on potential health and economic outcomes of RSV vaccination strategies

  • Review
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Treskova M, et al. Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data. PharmacoEconomics : 19 Jan 2021. Available from: URL: https://doi.org/10.1007/s40273-020-00991-7

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Reviewing evidence on potential health and economic outcomes of RSV vaccination strategies. PharmacoEcon Outcomes News 871, 32 (2021). https://doi.org/10.1007/s40274-021-7470-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7470-0

Navigation